Disc Medicine Raises $90M in Series B Funding

03 Sep, 2021

Disc Medicine Raises $90M in Series B Funding
Photo by CHUTTERSNAP on Unsplash

– Disc Medicine from Cambridge MA develops therapeutic candidates for hematology.
– Series B $90M round was led by OrbiMed and attracted new investor – Arix Bioscience as well as existing investors Atlas Venture, Novo Holdings and Access Biotechnology.
– The new investment will be aimed at developing the company’s hematology pipeline of therapeutic candidates.

Biotechnology Health Care Medical North America
Crunchbase icon

Content report

The following text will be sent to our editors: